Screener
iRadimed IRMD Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by iRadimed in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: iRadimed’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-029325
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Other income, net | 532 | 513 |
| Income before provision for income taxes | 7,769 | 5,945 |
| Provision for income tax expense | 1,951 | 1,258 |
| Net income | $5,818 | $4,687 |
| Net income per share: | ||
| Basic | $0.46 | $0.37 |
| Diluted | $0.45 | $0.37 |
| Weighted average shares outstanding: |
Item 1. Condensed Financial Statements
FAQ
- What is iRadimed's net income?
- iRadimed (IRMD) reported net income of $5.82M in Q1 2026.
- How has iRadimed's net income changed year-over-year?
- iRadimed's net income increased by 24.1% year-over-year, from $4.69M to $5.82M.
- What is the long-term trend for iRadimed's net income?
- Over 4 years (2021 to 2025), iRadimed's net income has grown at a 24.6% compound annual growth rate (CAGR), from $9.33M to $22.48M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about iRadimed's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude